[go: up one dir, main page]

FI811067L - Di- eller trisubstituerade xantiner med neuroleptiska verkningar foerfarande foer deras framstaellning samt dessa innehaollande mediciner - Google Patents

Di- eller trisubstituerade xantiner med neuroleptiska verkningar foerfarande foer deras framstaellning samt dessa innehaollande mediciner

Info

Publication number
FI811067L
FI811067L FI811067A FI811067A FI811067L FI 811067 L FI811067 L FI 811067L FI 811067 A FI811067 A FI 811067A FI 811067 A FI811067 A FI 811067A FI 811067 L FI811067 L FI 811067L
Authority
FI
Finland
Prior art keywords
xantiner
verkningar
trisubstituerade
mediciner
eller
Prior art date
Application number
FI811067A
Other languages
English (en)
Other versions
FI68831B (fi
FI68831C (fi
Inventor
Georges Philippossian
Marc Enslen
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of FI811067L publication Critical patent/FI811067L/fi
Publication of FI68831B publication Critical patent/FI68831B/fi
Application granted granted Critical
Publication of FI68831C publication Critical patent/FI68831C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI811067A 1980-05-02 1981-04-07 Foerfarande foer framstaellandet farmakologiskt aktiva di- ochtrisubstituerade xantiner FI68831C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH343180A CH643260A5 (fr) 1980-05-02 1980-05-02 1-allyl-3-butyl-8-methylxanthine, procede de preparation et utilisation dans un medicament.
CH343180 1980-05-02

Publications (3)

Publication Number Publication Date
FI811067L true FI811067L (fi) 1981-11-03
FI68831B FI68831B (fi) 1985-07-31
FI68831C FI68831C (fi) 1985-11-11

Family

ID=4255824

Family Applications (1)

Application Number Title Priority Date Filing Date
FI811067A FI68831C (fi) 1980-05-02 1981-04-07 Foerfarande foer framstaellandet farmakologiskt aktiva di- ochtrisubstituerade xantiner

Country Status (21)

Country Link
US (2) US4469698A (fi)
EP (1) EP0039780B1 (fi)
JP (1) JPS56169690A (fi)
AU (1) AU539258B2 (fi)
CA (1) CA1155841A (fi)
CH (1) CH643260A5 (fi)
CS (1) CS221829B2 (fi)
DD (1) DD158776A5 (fi)
DE (1) DE3169784D1 (fi)
DK (1) DK149856C (fi)
ES (1) ES502414A0 (fi)
FI (1) FI68831C (fi)
GB (1) GB2075505B (fi)
HK (1) HK49985A (fi)
HU (1) HU185256B (fi)
IL (1) IL62641A (fi)
MX (1) MX5974E (fi)
MY (1) MY8500517A (fi)
PH (2) PH17137A (fi)
PL (1) PL135383B1 (fi)
SG (1) SG20884G (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5338741A (en) * 1986-10-27 1994-08-16 Nestec S.A. 1-hydroxyalkylxanthines and medicaments containing them
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
EP0407651A3 (en) * 1989-07-10 1991-08-07 J. Uriach & Cia. S.A. Use of 1,3-diisobutyl-8-methylxanthine as a bronchodilator and antiallergy agent
WO1994019351A1 (en) * 1993-02-26 1994-09-01 Schering Corporation 2-benzyl-polycyclic guanine derivatives and process for preparing them
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
ATE247655T1 (de) * 1994-12-13 2003-09-15 Euro Celtique Sa Dreifachsubstituierte thioxanthine
EP0814809B1 (en) * 1994-12-13 2003-08-13 Euroceltique S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
FR2741455B1 (fr) * 1995-11-21 1997-12-26 Alcatel Optronics Procede de formation d'une nappe de fibres optiques inclinees a dioptres de couplage
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
DE10018834A1 (de) * 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
US9221821B2 (en) * 2012-06-05 2015-12-29 Forest Laboratories Holdings, Limited Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB701242A (en) * 1950-11-28 1953-12-23 Searle & Co Improvements in or relating to disubstituted 6-amino-1,2,3,4-tetrahydro-2,4-pyrimidinediones and methods of preparing the same
US2673848A (en) * 1951-12-29 1954-03-30 Searle & Co 3-alkenylxanthines and their lower 1-alkyl derivatives
GB759174A (en) * 1952-11-07 1956-10-17 Geigy Ag J R Improvements in diuretic acting xanthine derivatives
GB766754A (en) * 1954-01-27 1957-01-23 Geigy Ag J R New derivatives of 1.3-disubstituted and 1.3.8-trisubstituted xanthines and processes for their production
DE1091570B (de) * 1958-10-23 1960-10-27 Albert Ag Chem Werke Verfahren zur Herstellung von in 8-Stellung substituierten 1, 3-Dialkylxanthinen
GB982079A (en) * 1962-05-01 1965-02-03 Dresden Arzneimittel Process for the production of xanthine derivatives
US3740433A (en) * 1971-10-01 1973-06-19 Squibb & Sons Inc Anti-anxiety composition and method of use
US4089959A (en) * 1976-03-31 1978-05-16 Cooper Laboratories, Inc. Long-acting xanthine bronchodilators and antiallergy agents
CA1077932A (en) * 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
CH654008A5 (fr) * 1979-05-22 1986-01-31 Nestle Sa Procede de preparation de 1,3,7-trialkylxanthines.

Also Published As

Publication number Publication date
PH17660A (en) 1984-10-25
CH643260A5 (fr) 1984-05-30
DK158481A (da) 1981-11-03
AU539258B2 (en) 1984-09-20
MX5974E (es) 1984-09-11
AU6961781A (en) 1981-11-05
MY8500517A (en) 1985-12-31
US4581451A (en) 1986-04-08
US4469698A (en) 1984-09-04
DE3169784D1 (en) 1985-05-15
EP0039780B1 (fr) 1985-04-10
FI68831B (fi) 1985-07-31
CS221829B2 (en) 1983-04-29
HU185256B (en) 1984-12-28
GB2075505A (en) 1981-11-18
ES8207532A1 (es) 1982-10-01
GB2075505B (en) 1984-01-11
SG20884G (en) 1985-01-04
ES502414A0 (es) 1982-10-01
CA1155841A (en) 1983-10-25
PL230936A1 (fi) 1982-06-07
FI68831C (fi) 1985-11-11
HK49985A (en) 1985-07-05
IL62641A0 (en) 1981-06-29
PL135383B1 (en) 1985-10-31
DK149856B (da) 1986-10-13
DD158776A5 (de) 1983-02-02
JPS56169690A (en) 1981-12-26
DK149856C (da) 1987-05-25
EP0039780A1 (fr) 1981-11-18
IL62641A (en) 1985-01-31
PH17137A (en) 1984-06-04

Similar Documents

Publication Publication Date Title
FI811194L (fi) Kommunikationssystem med en informationssystem med en informationsbuss
FI810875L (fi) Torkvira med laog genomtraenglighet
FI813309L (fi) Med inline-elektronkanon foersett faergbildroer
FI812808L (fi) Fenylpiperazinderivat med antiagressiv aktivitet
FI810571L (fi) Tetrazolderivat foerfarande foer deras framstaellning samt dessa innehaollande saor-kompositioner
FI812175L (fi) Softsteroider med antiinflammationsverkan
FI810752L (fi) Sammalfoerpackning med foerpackningen omslutande handtag
FI810151L (fi) Med upprivbar oeppningsanording foersedd foerpackningsbehaollare
FI813266L (fi) Minnesstyrenhet med parallellbehandlade koeer
FI811067L (fi) Di- eller trisubstituerade xantiner med neuroleptiska verkningar foerfarande foer deras framstaellning samt dessa innehaollande mediciner
FI804082L (fi) Flaska med skruvfoerskjutning samt med originalitetssaekring
FI812365L (fi) Foer televisionsmottagare avsedd mottakteffektkaella synkroniserad med horisontalavlaenkningen
FI804045L (fi) Elektrostatisk faergsprutpistol med rotationsspridare
FI811069L (fi) Med en lyftanordning foersedd toemningskorg foer en varmpress
FI813415L (fi) Vaermevaexlare med stavmellanvaegg
FI810630L (fi) Stoedelement med boejlig huvuddel
FI813237L (fi) Lastvaexlare med stoedarm
FI812051L (fi) Avlaenkningskrets med korrigerad rasterdistorsion
FI810269L (fi) Blixtlaos med aendstoppare
FI811296L (fi) Vaetskebehaollare med sugroersoeppningsdon
FI812364L (fi) Avboejningskrets med linearitetskorrigering
FI803726L (fi) Vaog foersedd med en vibrerande straeng
FI812275L (fi) Oevervakningsanordning foer en pcm-regenerator med en felproevare foer kodregleringen
FI812744L (fi) Etanolframstaellning med hoegeffektiv bakteriodling
FI812639L (fi) Kommunikationsmultiplexer med duppelmikroprocessor

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: SOCIETE DES PRODUITS NESTLE S.A.